IE49709B1 - Pyrimidine derivatives - Google Patents

Pyrimidine derivatives

Info

Publication number
IE49709B1
IE49709B1 IE865/80A IE86580A IE49709B1 IE 49709 B1 IE49709 B1 IE 49709B1 IE 865/80 A IE865/80 A IE 865/80A IE 86580 A IE86580 A IE 86580A IE 49709 B1 IE49709 B1 IE 49709B1
Authority
IE
Ireland
Prior art keywords
pyrimidine
isopropylamino
general formula
hydroxy
pyrimidine derivatives
Prior art date
Application number
IE865/80A
Other versions
IE800865L (en
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of IE800865L publication Critical patent/IE800865L/en
Publication of IE49709B1 publication Critical patent/IE49709B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Abstract

Compounds of the general formula A4=H or OH A5=H or OH A6=H or OH A4=A5=A6=H excluded are prepared by reducing compounds of the general formula A'4=H, alkoxy or aralkyloxy A'5=H, alkoxy or aralkyloxy A'6=H, alkoxy or aralkyloxy A'4=A'5=A'6=H excluded with hydrogen in the presence of a hydrogenation catalyst, e.g. palladium. The compounds I are of therapeutical interest.

Description

The invention relates to a method for the preparation of hydroxy derivatives of 2-isopropylamino-pyrimidine of the general formula I wherein each of A^, Ag and Ag independently represents a hydrogen atom or a hydroxy group with the proviso that at least one of A4, and Ag and Ag does not represent a hydrogen atom. These compounds are claimed per se in our copending Application No. +77/80, and are of therapeutical interest.
The invention provides a method for the preparation of hydroxy derivatives of 2-isopropylamino-pyrimidine of the general formula I as above defined, the method comprising treating halogeno derivatives of 2-isopropylamino-pyrimidine of the general formula II wherein each of A'4, A'g and Α'θ independently represents a hydrogen or halogen atom with the proviso that at least one of A'^, A'g and A'g does not represent a hydrogen atom with a mineral base in water at from 100°C to 150°C in the presence of copper.
The invention is illustrated by the following Examples.
EXAMPLE 1; 2-isopropylami no-5-hydroxy-pyrimi di ne Into a one litre reactor were poured 80 ml of water, g of sodium hydroxide, some copper powder and 4.3 g (0.02 mol) of 2-isopropylamino-5-bromo-pyrimidine; the reaction mixture was maintained at 130°C to 135°C for 1 hour under stirring and then at 130°C to 140°C for about 12 hours, also under stirring.
After filtration off of the copper, the reaction mixture was extracted twice with chloroform. The combined extracts were acidified with acetic acid to pH 6.5 to 7.0. The solution was then saturated with sodium chloride causing precipitation of the product, which was collected and washed with water and then with pentane.
The product was then taken up in diethyl ether and treated with carbon black. The solution was concentrated, causing reprecipitation of the product which was collected and recrystallised from water or from isopropyl acetate. The crystals were dried to give 2.45 g (yield 80%) of 2-i'sopropylamino-5-hydroxy-pyrimidine. Elemental analysis showed the expected empirical fonnula CyH^NgO. The 40709 2-isopropylamino-5-bromo-pyrinridine starting material had been readily obtained by reacting, in stoichiometric proportions, 2-isopropylamino-pyrimidine and N-bromo-succinimide in the presence of acetic acid (yield 84%).
EXAMPLE 2: 2-isopropylamino-4-hydroxy-pyrimidine The method described in Example 1 was repeated except that 2-isopropylamino-4-chloro-pyrimidine was used instead of 2-isopropylamino-5-bromo-pyrimidine. Yield was 77% of a white crystalline product melting at 140°C (Tottoli), elemental analysis of which showed a good correspondence with the formula CyH^NgO. Structural analysis (U.V. Spectrum) confirmed the position of the hydroxy group.
EXAMPLE 3: 2-i sopropylami no-4,6-di hydroxy-pyrimi di ne The method described in Example 1 was repeated except that 2-isopropylamino-4,6-dichloro-pyrimidine was used instead of 2-isopropylamino-5-bromo-pyrimidine. Yield was 73% of a white crystalline product melting at 221-225°C (Tottoli) with decomposition, elemental analysis of which showed good correspondence with the formula CyH^Oj, HCl. Structural analysis (U.V. Spectrum) confirmed the positions of the hydroxy groups.

Claims (3)

  1. I. A method for the preparation of a hydroxy derivative of 2-isopropylamino-pyrimidine of the general formula I as herein defined, the method comprising treating a halogeno derivative of 5 2-isopropylamino-pyrimidine of the general fonnula II as herein defined with a mineral base in water at from 100°C to 150°C in the presence of copper.
  2. 2. A method for the preparation of a hydroxy derivative of 2-isopropylamino-pyrimidine of the general formula I as herein 10 defined, the method being substantially as described herein with reference to any one of the Examples.
  3. 3. 2-isopropylamino-pyrimidine of general formula I whenever prepared by the method claimed in either of the preceding claims.
IE865/80A 1979-04-30 1980-04-28 Pyrimidine derivatives IE49709B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
IE800865L IE800865L (en) 1980-10-30
IE49709B1 true IE49709B1 (en) 1985-11-27

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
IE865/80A IE49709B1 (en) 1979-04-30 1980-04-28 Pyrimidine derivatives
IE864/80A IE49591B1 (en) 1979-04-30 1980-04-28 Pyrimidine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE864/80A IE49591B1 (en) 1979-04-30 1980-04-28 Pyrimidine derivatives

Country Status (26)

Country Link
JP (2) JPS55145671A (en)
AR (2) AR222870A1 (en)
AT (2) AT380013B (en)
BE (2) BE882593A (en)
CH (2) CH645361A5 (en)
DK (2) DK183780A (en)
EG (2) EG14284A (en)
ES (2) ES491000A0 (en)
FI (2) FI66358C (en)
FR (2) FR2455588A1 (en)
GB (2) GB2055801B (en)
HK (2) HK55683A (en)
IE (2) IE49709B1 (en)
IN (2) IN154067B (en)
IT (2) IT1141296B (en)
LU (2) LU82332A1 (en)
MA (1) MA18824A1 (en)
MX (2) MX5878E (en)
MY (2) MY8400204A (en)
NL (2) NL8002271A (en)
NO (2) NO154055C (en)
NZ (2) NZ193421A (en)
OA (2) OA06527A (en)
PT (2) PT71154A (en)
SG (2) SG22583G (en)
ZA (2) ZA801958B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (en) * 1987-03-13 1988-09-26
JPS645795U (en) * 1987-06-26 1989-01-13
JPH01100695U (en) * 1987-12-21 1989-07-06
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines

Also Published As

Publication number Publication date
NO154056B (en) 1986-04-01
AR222869A1 (en) 1981-06-30
PT71154A (en) 1980-05-01
JPS55145671A (en) 1980-11-13
BE882593A (en) 1980-07-31
IN154066B (en) 1984-09-15
ES490999A0 (en) 1981-02-16
NO154055C (en) 1986-07-09
MA18824A1 (en) 1980-12-31
IE800864L (en) 1980-10-30
MX5878E (en) 1984-08-16
AT380013B (en) 1986-03-25
FI66359C (en) 1984-10-10
DK183880A (en) 1980-10-31
OA06525A (en) 1981-07-31
GB2055801A (en) 1981-03-11
PT71155A (en) 1980-05-01
IT8021542A0 (en) 1980-04-22
CH645361A5 (en) 1984-09-28
JPS55145670A (en) 1980-11-13
NZ193422A (en) 1981-12-15
ES8103061A1 (en) 1981-02-16
HK55583A (en) 1983-11-25
MY8400204A (en) 1984-12-31
GB2054556A (en) 1981-02-18
DK183780A (en) 1980-10-31
NO154056C (en) 1986-07-09
MY8400203A (en) 1984-12-31
NL8002271A (en) 1980-11-03
NO154055B (en) 1986-04-01
FI801083A (en) 1980-10-31
ATA221680A (en) 1985-08-15
NL8002272A (en) 1980-11-03
BE882594A (en) 1980-07-31
GB2055801B (en) 1983-02-09
SG22283G (en) 1983-12-16
ATA221580A (en) 1985-08-15
GB2054556B (en) 1983-01-26
IT8021543A0 (en) 1980-04-22
SG22583G (en) 1983-12-16
FR2455588B1 (en) 1983-04-15
IE49591B1 (en) 1985-10-30
IT1141487B (en) 1986-10-01
FI66359B (en) 1984-06-29
NO801234L (en) 1980-10-31
NO801235L (en) 1980-10-31
ZA801960B (en) 1981-04-29
IT1141296B (en) 1986-10-01
FR2455588A1 (en) 1980-11-28
FI801084A (en) 1980-10-31
LU82332A1 (en) 1980-07-02
AR222870A1 (en) 1981-06-30
ZA801958B (en) 1981-04-29
FI66358C (en) 1984-10-10
EG14284A (en) 1983-09-30
OA06527A (en) 1981-07-31
LU82333A1 (en) 1980-07-02
EG14259A (en) 1983-09-30
ES491000A0 (en) 1981-02-16
JPS6116272B2 (en) 1986-04-28
JPS6116273B2 (en) 1986-04-28
FR2455589A1 (en) 1980-11-28
IE800865L (en) 1980-10-30
MX6514E (en) 1985-06-26
CH645633A5 (en) 1984-10-15
IN154067B (en) 1984-09-15
ES8103060A1 (en) 1981-02-16
FI66358B (en) 1984-06-29
AT380012B (en) 1986-03-25
HK55683A (en) 1983-11-25
NZ193421A (en) 1981-11-19
FR2455589B1 (en) 1981-07-10

Similar Documents

Publication Publication Date Title
US4136101A (en) Process for preparing dialkyl (p-aminobenzoyl) glutamates
IE49709B1 (en) Pyrimidine derivatives
US4382040A (en) Process for production of 2,3-dimercaptopropane-1-sulfonic acid and its salts
US4131617A (en) Preparation of new isobutylramide derivatives
EP0052094A1 (en) N-isopropoxycarbonylphenylglycines and their production
US3002011A (en) Intermediates and processes for producing alpha-lipoic acid
HU213315B (en) Process for producing arylacetic acids and their alkali metal salts
US4486599A (en) Process for preparing the 2',4'-difluoro-4-hydroxy-(1,1'-diphenyl)-3-carboxylic acid
EP0010799A1 (en) A process for the preparation of 3-azabicyclo(3.1.0)hexane derivatives and modifications thereof
US4824966A (en) Process for the production of 4-hydroxy-2-oxo-pyrrolidin-1-yl acetamide
KR850001529B1 (en) Process for the preparation of amino acid phenol-ester derivation
US3984461A (en) 3-0-(Beta-carbobenzyloxypropionyl)-11-oxo-18-beta-olean-12-en-30-oic acid
NZ201412A (en) Preparation of 4-aminobutyramide
JPH0115511B2 (en)
EP0222172A2 (en) N-Glycolylneuraminic acid derivative
JP2855871B2 (en) Method for producing thiomalic acid
US4189444A (en) Process for the preparation of N,N'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein
SU595312A1 (en) Method of preparing pyrimidine 2,4,6-substituted perchlorates
US4476306A (en) Method of preparing 2,4-dihydroxypyrimidine
JPS6337104B2 (en)
US4550193A (en) Process for the preparation of 2,3-dimercaptosuccinic acid and its lower alkyl esters
US4960917A (en) Process for the preparation of an acexamic acid derivatives
KR840001985B1 (en) Process for preparing isopropylamino pyrimidine hydroxy derivatives
KR830000147B1 (en) Method for preparing chiazolidine-4-carboxylic acid derivative
KR850000612B1 (en) Process for preparing alpha-amino benzyl penicillin esters